An observational study in Post-induction Hypotension, Eadyn and Cerebral and Kidney Regional Saturation, sponsored by Haseki Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-09-21.
Sponsored by Haseki Training and Research Hospital · Observational
Our aim is to identify patients who may experience hypotension during anesthesia induction. Intraoperative hemodynamic stability plays an important role in tissue oxygenation. Although the duration of hypotension can be kept short with the necessary interventions, it is important that hypotension is predictable in order to prevent intraoperative complications and postoperative organ damage.
40 patients scheduled for open heart surgery will be monitored from one minute before anesthesia is administered until ten minutes after. Patients will be divided into two groups based on the presence or absence of hypotension during the monitoring period. All patients will be monitored according to a standardized procedure. Demographic data, non-invasive and invasive hemodynamic parameters, primarily Eadyn, and cerebral and renal tissue saturation data will be collected. Moreover, vasopressor administration in response to hypotension will be recorded.
Introduction: Hypotension during and after the induction of anesthesia is a common occurrence. Several factors may contribute to post-induction hypotension, including prolonged fasting, underlying comorbidities, sympathetic blockade induced by anesthetic agents, vasodilation, decreased preload, and reduced cardiac contractility.
Numerous studies have identified factors and predictors associated with post-induction hypotension; however, most of these predictors are non-modifiable. Previous research has shown that patients at risk for post-induction hypotension can be identified using variables such as the inferior vena cava collapsibility index, carotid intima-media thickness, pulse pressure variation (PPV), and stroke volume variation (SVV).
Nevertheless, most of these studies have focused on assessing the cardiovascular system using preload- and fluid-responsiveness-related parameters, while the interaction between the arterial system and the ventricle has often been overlooked. Dynamic arterial elastance (Eadyn), defined as the ratio between pulse pressure variation (PPV) and stroke volume variation (SVV), integrates the flow generated by the heart and the opposing pressure from the arterial system during the respiratory cycle, and has been proposed as a functional measure of arterial load.
Furthermore, recent studies suggest that post-induction hypotension is associated with arterial vasodilation rather than venous dilation or decreased myocardial contractility.
In current anesthetic practice, interventions are typically applied only after hypotension has developed. We hypothesize that if patients at risk of developing hypotension during anesthesia induction can be identified in advance, prophylactic administration of fluids and vasopressors could reduce the duration and severity of hypotension, thereby preventing potential intraoperative complications and postoperative organ dysfunction.
Material method: Patients scheduled for open heart surgery after October 17, 2025, are eligible for this study after ethical board approval. Inclusion criterions are (1) patients aged between 18-90 years with American Society of Anaesthesiologists (ASA) Physical Status classification I to III, (2)planned open heart surgery. Written informed consent will be obtained from all participants.
Exclusion criteria are refusal to participate in the study, younger than 18 years of age; those with arrhythmias (including atrial fibrillation or frequent premature beats); severe valvular heart disease (aortic or mitral stenosis or insufficiency); severe heart failure (ejection fraction \< 40%); congenital heart disease; pre-existing severe pulmonary disease; chronic kidney disease requiring dialysis; severe peripheral vascular disease; morbid obesity; and patients undergoing emergency surgery.
All patients received standard general anesthesia with monitoring that included Masimo SedLine -NIRS(noninvasive regional saturation), Mostcare invasive hemodynamic monitoring, and conventional standard monitors; Anesthesia induction was performed with midazolam (0.025 mg/kg), propofol (1.5-2.5 mg/kg), lidocaine (1 mg/kg), and rocuronium (1 mg/kg). Anesthetics and opioid administration was titrated according to hemodynamic parameters and Patient State Index (PSI) values between 25 and 50.
For each patient, both the total cumulative dose of ephedrine administered and the number of times it was given were recorded.
885 studies on the registry are indexed under Hypotension; 195 are open to participants now.
This study's planned enrollment of 40 is below the median of 90 across 265 observational studies indexed under Hypotension.
Browse Hypotension studies →Haseki Training and Research Hospital is the lead sponsor of 78 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients diagnosed with coronary artery disease who were scheduled to undergo elective open-heart surgery were included in the study.
Inclusion Criteria: • American Society of Anaesthesiologists (ASA) Physical Status classification I to III
Exclusion Criteria: • Age \< 18 years
Patients whose systolic blood pressure decreased below 90 mmHg or whose mean arterial pressure dropped by more than 30% from the preinduction baseline value were classified as hypotensive
Device: mostcare hemodynamic monitor · Device: Masimo NIRS · Device: Hemodynamic Measurements on Standart Monitoring
Patients whose systolic blood pressure remained above 90 mmHg and whose mean arterial pressure did not decrease by more than 30% from the preinduction baseline value were classified as non-hypotensive.
Device: mostcare hemodynamic monitor · Device: Masimo NIRS · Device: Hemodynamic Measurements on Standart Monitoring
Invasive hemodynamic variables including dynamic arterial elastance (Eadyn), stroke volume variation (SVV), pulse pressure variation (PPV), cardiac index (CI), oxygen delivery (DO₂), and cardiac power output (CPO) were obtained using the MostCare monitor.
Cerebral and renal tissue oxygen saturation(rso2) values were measured using the Masimo device.
Heart rate and peripheral oxygen saturation were measured using standard noninvasive monitoring.
Eadyn
Dynamic Arterial Elastance
Time frame: Perioperative
rso2
Cerebral and Kidney Regional Saturation
Time frame: Perioperative
Intraoperative hypotension
Explanatory outcome
Time frame: perioperative
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2025 (actual). Primary completion is estimated for Dec 2026, 15 months after the start.
Of 146 non-industry observational studies under Hypotension, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 25. This study's planned 15 months is above that.
Counting every sponsor, half of 151 studies reached it within 11 months; a quarter within 5 and three quarters within 24.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Haseki Training and Research Hospital